Prescription Division of Adcock Ingram
The Prescription division is the largest segment of the Adcock Ingram business with a turnover exceeding R1.8 billion and is ranked 3 (three) by value in the pharmacy market .
This division markets medicines which are usually prescribed by a healthcare professional.
- Generic medicines make up the largest share by value, with Genpayne as the leading brand.
- The ARV portfolio is growing rapidly, particularly in the private market and includes a triple combination.
- Strategic alliances with multinational partners offer a mutually beneficial relationship.
The manufacturing facility at Wadeville offers capacity for own manufacture and partners alike.